Evidence map›Paper›PMID 41331019›Full record

ArticleNPJ precision oncology2025

Customized transformer for lymph node metastasis prediction from lung adenocarcinoma histology in a multicentric study.

Huibo Zhang, Tao Wang, Junwei Feng, Jie Wu, Junju He, Yang Liu, Qibin Song, Bin Xu

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huibo Zhang *Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Tao Wang *Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Junwei Feng *Department of Interventional Radiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jie WuCancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Junju HeCancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Yang LiuDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, China. 601032@csu.edu.cn.
Qibin SongCancer Center, Renmin Hospital of Wuhan University, Wuhan, China. qibinsong@whu.edu.cn.
Bin XuCancer Center, Renmin Hospital of Wuhan University, Wuhan, China. xubin_oncology@whu.edu.cn.

Funding

National Natural Science Foundation of China 82203502National Natural Science Foundation of China 82403850the Cross-Innovation Talent project of Renmin Hospital of Wuhan University JCRCGW-2022-002
6 · The paper itself

Abstract

Reliable lymph node metastasis (LNM) assessment underpins staging and treatment decisions in lung adenocarcinoma (LUAD), yet approximately 10% of patients remain pNx due to sampling limitations. Existing LNM prediction methods mainly rely on imaging or molecular data, while the potential of histopathological whole-slide images (WSIs) remains underexplored. We introduce CTMIL, a customized transformer-based multiple instance learning framework for predicting LNM directly from primary LUAD WSIs. Three CTMIL models were trained on 320 TCGA cases using patch-level features extracted from ResNet50, InceptionResNetV2, and UNI backbones, and internally validated on 80 held-out cases. External evaluation on two independent cohorts (XY cohort, 149 cases, and RM cohort, 164 cases) showed that CTMIL models consistently outperformed attention-based, TransMIL, and baseline approaches under identical inputs. The best-performing model, UNI_CTMIL, achieved AUROCs of 0.8640, 0.8216, and 0.8090 on the validation, XY, and RM cohorts, respectively. Interpretability analyses showed that UNI_CTMIL attends to metastatic hallmarks such as micropapillary and solid patterns, mucin, poor differentiation, and high tumor cell density. These findings highlight CTMIL's promise for histology-based LNM prediction, potentially in pNx cases.

Identifiers

PMID41331019
PMCPMC12796217

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.